Prevent Biometrics Buys Assets of X2 Biosystems

preventPrevent Biometrics, a Minneapolis-based developer of a real-time system for monitoring head impacts in contact sports, acquired the head impact monitoring assets of Seattle-based X2 Biosystems.

The terms of the transaction – which brings together the two head impact monitoring technologies, Prevent’s Impact Monitor Mouthguard, and X2’s skin patch-based platform – were not released.

Prevent Biometrics will now hold nine issued U.S. patents and 12 issued international patents related to measuring and displaying head impacts.

X2 Biosystem has developed the Integrated Concussion Evaluation (“ICE”) Application, a mobile implementation of the internationally standardized Sports Concussion Assessment Tool (SCAT) test for athlete concussion evaluations. X2 ICE allows trainers, team physicians and healthcare providers to collaborate real-time by providing neurocognitive baseline testing, post-impact assessments, remove-from-play decision support, and recovery and return-to-play monitoring.
Backers in the company included Maxim Ventures, the strategic investment arm of analog chip-maker Maxim Integrated, and Chris Siege.

Established in 2015 in Minneapolis as a Cleveland Clinic spinoff and led by Steve Washburn, co-founder and CEO, Prevent Biometrics has developed head impact monitoring technology that accurately measures head impact characteristics in real time.

Read the press release here



Join the discussion